Post-neonatal drop in alveolar SP-A expression: Biological significance for increased vulnerability to SIDS?

Pediatric Pulmonology

Volumn 43, Issue 2, 2008, Pages 160-168

  Stray Pedersen, Arne ^a   Vege, Ashild ^a   Stray Pedersen, Asbjorg ^a   Holmskov, Uffe ^b   Rognum, Torleiv Ole ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Immunohistochemistry; Infant; Innate immunity; Lung; SIDS; Surfactant protein A

Indexed keywords

SURFACTANT PROTEIN A;

ANTIBODY DETECTION; ARTICLE; AUTOPSY; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUDDEN INFANT DEATH SYNDROME;

ADULT; AGE DISTRIBUTION; AGE FACTORS; ANTIBODIES, MONOCLONAL; AUTOPSY; BIOLOGICAL MARKERS; CHILD, PRESCHOOL; DOWN-REGULATION; FEMALE; FETAL DEATH; FETUS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; MALE; NORWAY; OBSERVER VARIATION; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SUDDEN INFANT DEATH;

EID: 39449121118     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20750     Document Type: Article

References (24)

1. Madsen J, Tornoe I, Nielsen O, Koch C, Steinhilber W, Holmskoy U. Expression and localization of lung surfactant protein A in human tissues. Am J Respir Cell Mol Biol 2003;29:591-597.
2. Khubchandani KR, Snyder JM. Surfactant protein A (SP-A): the alveolus and beyond. FASEB J 2001;15:59-69.
3. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 1997;77:931-962.
4. Hermans C, Bernard A. Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med 1999;159:646-678.
5. Krous HF, Beckwith JB, Byard RW, Rognum TO, Bajanowski T, Corey T, Cutz E, Hanzlick R, Keens TG, Mitchell EA. Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach. Pediatrics 2004;114:234-238.
6. Rognum TO, Arnestad M, Bajanowski T, Banner J, Blair P, Borthne A, Byard R, Gaustad P, Gregersen M, Grogaard J, Holter E, Isaksen C, Jorgensen J, Krous H, de Lange C, Moore I, Morland J, Opdal S, Rasten-Almqvist P, Schlaud M, Sidebotham P, Skullerud K, Stoltenburg-Didinger G, Stray-Pedersen A, Sveum F, Vege A. Consensus on diagnostic criteria for the exclusion of SIDS. Scand J Forens Sci 2003;9:62-73.
7. Blackwell CC, Moscovis SM, Gordon AE, Al Madani OM, Hall ST, Gleeson M, Scott RJ, Roberts-Thomson J, Weir DM, Busuttil A. Cytokine responses and sudden infant death syndrome: genetic, developmental, and environmental risk factors. J Leukoc Biol 2005;78:1242-1254.
8. Rognum TO, Byard RW. Sudden infant death syndrome, etiology and epidemiology. In: Payne-James J, Byard RW, Corey T, Henderson C, editors. Encyclopedia of forensic and legal medicine, 2nd edition. Amsterdam: Elsevier/Academic Press; 2005. pp 117-127.
9. Vege A, Rognum TO, Scott H, Aasen AO, Saugstad OD. SIDS cases have increased levels of interleukin-6 in cerebrospinal fluid. Acta Paediatr 1995;84:193-196.
10. Vege A, Rognum TO. Sudden infant death syndrome, infection and inflammatory responses. FFMS Immunol Med Microbiol 2004;42:3-10.
11. Stoltenberg L, Saugstad OD, Rognum TO. Sudden infant death syndrome victims show local immunoglobulin M response in tracheal wall and immunoglobulin A response in duodenal mucosa. Pediatr Res 1992;31:372-375.
12. Thrane PS, Rognum TO, Brandtzaeg P. Up-regulated epithelial expression of HLA-DR and secretory component in salivary glands: reflection of mucosal immunostimulation in sudden infant death syndrome. Pediatr Res 1994;35:625-628.
13. Vege A, Rognum TO, Anestad G. IL-6 cerebrospinal fluid levels are related to laryngeal IgA and epithelial HLA-DR response in sudden infant death syndrome. Pediatr Res 1999;45:803-809.
14. Stray-Pedersen A, Rognum TO. Evaluation of circumstances and clinical history in SUDI. Scand J Forens Sci 2004;10:77-79.
15. Gregersen M, Rajs J, Laursen H, Baandrup U, Frederiksen P, Gidlund E. Pathologic criteria for the Nordic study of SIDS. In: Rognum TO, editor. Sudden infant death syndrome new trends in the nineties. Oslo: Scandinavian University Press; 1995. pp 50-58.
16. Sainte-Marie G. A paraffin embedding technique for studies employing immunofluorescence. J Histochem Cytochem 1962;10:250-260.
17. Khoor A, Gray ME, Hull WM, Whitsett JA, Stahlman MT. Developmental expression of SP-A and SP-A mRNA in the proximal and distal respiratory epithelium in the human fetus and newborn. J Histochem Cytochem 1993;41:1311-1319.
18. Zhu BL, Ishida K, Oritani S, Quan L, Taniguchi M, Li DR, Fujita MQ, Maeda H. Immunohistochemical investigation of pulmonary surfactant-associated protein A in fire victims. Leg Med (Tokyo) 2001;3:23-28.
19. Holmskov H, Thiel S, Jensenius JC. Collectins and licolins: humoral lectins of the innate immune defense. Annu Rev Immunol 2003;21:547-578.
20. Rooney SA. Lung surfactant. Environ Health Perspect 1984;55:205-226.
21. Midgley PC, Holownia P, Smith J, Moore M, Russell K, Oates N, Shaw JC, Honour JW. Plasma cortisol, cortisone and urinary glucocorticoid metabolites in preterm infants. Biol Neonate 2001;79:79-86.
22. Vege A, Rognum TO, Opdal SH. SIDS-changes in the epidemiological pattern in eastern Norway 1984-1996. Forensic Sci Int 1998;93:155-166.
23. Blackwell CC, Gordon AE, James VS, MacKenzie DA, Mogensen-Buchanan M, El Ahmet OR, Al Madani OM, Toro K, Csukas Z, Sotonyi P, Weir DM, Busuttil A. The role of bacterial toxins in sudden infant death syndrome (SIDS). Int J Med Microbiol 2002;291:561-570.
24. LeVine AM, Whitsell JA, Gwozdz JA, Richardson TR, Fisher JH, Burhans MS, Korfhagen TR. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 2000;165:3934-3940.